Md. Code Ann., Health-Gen. § 21-2C-14
Upper payment limits
Effective Oct 1, 2025Added by Acts 2023, c. 39, § 1, eff. April 11, 2023; Acts 2023, c. 40, § 1, eff. April 11, 2023. Amended by Acts 2025, c. 610, § 1, eff. Oct. 1, 2025; Acts 2025, c. 611, § 1, eff. Oct. 1, 2025.State of Maryland
(1) Purchased or paid for by a unit of State or local government or an organization on behalf of a unit of State or local government, including:
- (i) State or county correctional facilities;
- (ii) State hospitals; and
- (iii) Health clinics at State institutions of higher education;
- (2) Paid for through a health benefit plan on behalf of a unit of State or local government, including a county, bicounty, or municipal employee health benefit plan; or
- (3) Purchased for or paid for by the Maryland State Medical Assistance Program.
In accordance with the plan of action approved by the Legislative Policy Committee on October 22, 2024, the Board may set upper payment limits through regulations for prescription drug products that are:
Added by Acts 2023, c. 39, § 1, eff. April 11, 2023; Acts 2023, c. 40, § 1, eff. April 11, 2023. Amended by Acts 2025, c. 610, § 1, eff. Oct. 1, 2025; Acts 2025, c. 611, § 1, eff. Oct. 1, 2025.